文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

休克时直接评估微循环:一项随机对照多中心研究

Direct assessment of microcirculation in shock: a randomized-controlled multicenter study.
PubMed 文献 · Intensive Care Med · 2023-06-06
一句话结论在休克患者治疗中整合舌下微循环灌注变量会改变治疗,但未改善30天生存。

这项随机、前瞻性多中心试验纳入141例休克患者(心源性77例、心脏术后27例、脓毒症休克22例),入ICU时动脉乳酸>2 mmol/L且液体复苏后仍需血管活性药。患者随机分为常规治疗组或整合舌下微循环灌注变量组,用侧流暗场视频显微镜在入ICU时(±4 h)和24(±4)小时后盲法测量。干预组更多患者在随后1小时内调整血管活性药或液体(66.7% vs 41.8%,p=0.009);24小时微循环值和30天死亡率无差异(粗率:32例(47.1%)vs 25例(34.7%),RR 1.39(0.91-1.97);Cox回归:HR 1.54(95%CI 0.90-2.66,p=0.118))。结论:整合舌下微循环灌注变量导致治疗改变,但未改善生存。

要点

  • 休克患者(乳酸>2 mmol/L且液体复苏后仍需血管活性药)整合舌下微循环变量未改善30天死亡率:干预组47.1% vs 常规组34.7%,RR 1.39(0.91-1.97)。
  • Cox回归显示30天死亡风险无显著差异:HR 1.54(95%CI 0.90-2.66,p=0.118)。
  • 干预组在随后1小时内调整血管活性药物或液体的比例显著更高:66.7% vs 41.8%(p=0.009)。
  • 入ICU后24小时微循环值两组无差异。
  • 研究未发生严重不良事件(SAEs)。

适用人群与场景

  • ICU收治的休克患者,动脉乳酸>2 mmol/L且充分液体复苏后仍需血管活性药,不论休克病因。
  • 纳入心源性休克(n=77)、心脏术后(n=27)和脓毒症休克(n=22)患者。

处置流程与药物剂量

  • 所有患者在入ICU时(±4 h)和24(±4)小时后用侧流暗场(SDF)视频显微镜进行序贯舌下测量,操作对治疗团队设盲。
  • 干预组将舌下微循环灌注变量整合到治疗计划中,常规组按常规治疗。

研究设计与关键结果

  • 随机、前瞻性、多中心试验纳入141例休克患者,干预组69例、常规组72例;无严重不良事件(SAEs)。
  • 干预组在随后1小时内调整血管活性药物或液体的患者显著更多:66.7% vs 41.8%(p=0.009)。
  • 入ICU后24小时微循环值两组无差异。
  • 30天死亡率:干预组32例(47.1%)vs 常规组25例(34.7%),RR 1.39(0.91-1.97);Cox回归HR 1.54(95%CI 0.90-2.66,p=0.118)。
  • 次要终点包括ICU和住院时间及6个月死亡率。

证据类型、等级与局限

  • 证据类型:随机、前瞻性、多中心临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在休克患者中将舌下微循环灌注变量整合进治疗计划可导致更多血管活性药物或液体调整(66.7% vs 41.8%,p=0.009),但未改善30天生存(RR 1.39(0.91-1.97);HR 1.54(95%CI 0.90-2.66,p=0.118));作者认为该策略未改善生存。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Shock is a life-threatening condition characterized by substantial alterations in the microcirculation. This study tests the hypothesis that considering sublingual microcirculatory perfusion variables in the therapeutic management reduces 30-day mortality in patients admitted to the intensive care unit (ICU) with shock.

METHODS: This randomized, prospective clinical multicenter trial-recruited patients with an arterial lactate value above two mmol/L, requiring vasopressors despite adequate fluid resuscitation, regardless of the cause of shock. All patients received sequential sublingual measurements using a sidestream-dark field (SDF) video microscope at admission to the intensive care unit (± 4 h) and 24 (± 4) hours later that was performed blindly to the treatment team. Patients were randomized to usual routine or to integrating sublingual microcirculatory perfusion variables in the therapy plan. The primary endpoint was 30-day mortality, secondary endpoints were length of stay on the ICU and the hospital, and 6-months mortality.

RESULTS: Overall, we included 141 patients with cardiogenic (n = 77), post cardiac surgery (n = 27), or septic shock (n = 22). 69 patients were randomized to the intervention and 72 to routine care. No serious adverse events (SAEs) occurred. In the interventional group, significantly more patients received an adjustment (increase or decrease) in vasoactive drugs or fluids (66.7% vs. 41.8%, p = 0.009) within the next hour. Microcirculatory values 24 h after admission and 30-day mortality did not differ [crude: 32 (47.1%) patients versus 25 (34.7%), relative risk (RR) 1.39 (0.91-1.97); Cox-regression: hazard ratio (HR) 1.54 (95% confidence interval (CI) 0.90-2.66, p = 0.118)].

CONCLUSION: Integrating sublingual microcirculatory perfusion variables in the therapy plan resulted in treatment changes that do not improve survival at all.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Bruno RR, Wollborn J, Fengler K, et al. Direct assessment of microcirculation in shock: a randomized-controlled multicenter study. Intensive Care Med. 2023. PMID: 37278760. doi:10.1007/s00134-023-07098-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。